SRA1 Monoclonal Antibody

    • Catalog No.:YM0595
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human
      • Target:
      • SRA1
      • Gene Name:
      • SRA1
      • Protein Name:
      • Steroid receptor RNA activator 1
      • Human Swiss Prot No:
      • Q9HD15
      • Mouse Swiss Prot No:
      • Q80VJ2
      • Immunogen:
      • Purified recombinant fragment of SRA1 expressed in E. Coli.
      • Specificity:
      • SRA1 Monoclonal Antibody detects endogenous levels of SRA1 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Monoclonal, Mouse
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:200 - 1:1000. ELISA: 1:10000.. IF 1:50-200
      • Purification:
      • Affinity purification
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • SRA1;PP7684;Steroid receptor RNA activator 1;Steroid receptor RNA activator protein;SRAP
      • Molecular Weight(Da):
      • 24kD
      • References:
      • 1. Rainer B. Lanz, Steven S. Chua, Niall Barron. Mol. Cell. Biol, Oct 2003; 23: 7163 - 7176.
        2. Shilpa Chooniedass-Kothari, Mohammad Kariminia Hamedani, Sandy Troup. Int J Cancer. 2006 Feb 15;118(
      • Background:
      • Both long non-coding and protein-coding RNAs are transcribed from this gene, and they represent alternatively spliced transcript variants. This gene was initially defined as a non-coding RNA, which is a coactivator for several nuclear receptors (NRs) and is associated with breast cancer. It has now been found that this gene is involved in the regulation of many NR and non-NR activities, including metabolism, adipogenesis and chromatin organization. The long non-coding RNA transcripts interact with a variety of proteins, including the protein encoded by this gene. The encoded protein acts as a transcriptional repressor by binding to the non-coding RNA. [provided by RefSeq, Mar 2012],
      • Function:
      • function:Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand-dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis.,miscellaneous:Appears to be the first example of a new class of functional RNAs also able to encode a protein.,similarity:Belongs to the SRA1 family.,subunit:SRA1 RNA exists in a ribonucleoprotein complex containing NCOA1. The RNA also forms a complex with PUS1 and RARG in the nucleus. Interacts with AR.,tissue specificity:Highly expressed in liver and skeletal muscle and to a lesser extent in brain. Als
      • Subcellular Location:
      • Nucleus . Cytoplasm .
      • Expression:
      • Highly expressed in liver and skeletal muscle and to a lesser extent in brain. Also expressed in both normal and tumorigenic breast epithelial cell lines. Significantly up-regulated in human tumors of the breast, ovary, and uterus.
      • Products Images
      • Western Blot analysis using SRA1 Monoclonal Antibody against truncated SRA recombinant protein (1), human ovary cancer tissue lysate (2) and A431 cell lysate (3).
      • Immunohistochemistry analysis of paraffin-embedded human skin carcinoma (left) and breast carcinoma (right), showing cytoplasmic and membrane localization with DAB staining using SRA1 Monoclonal Antibody.